Practice guideline for the treatment of patients with nicotine dependence

American Journal of Psychiatry

Volumn 153, Issue 10 SUPPL., 1996, Pages 1-31

  Hughes, J R ^a   Fiester, S ^a   Goldstein, M ^a   Resnick, M ^a   Rock, N ^a   Ziedonis, D ^a   McIntyre, J S ^a   Charles, S C ^a   Zarin, D A ^a   Pincus, H A ^a   Altshuler, K Z ^a   Ayres, W H ^a   Bittker, T ^a   Blinder, B ^a   Clayton, P J ^a   Cook, I ^a   Dickstein, L ^a   Egger, H ^a   Flamm, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; BICARBONATE; BUSPIRONE; CARBON MONOXIDE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CORTICOTROPIN; COTININE; LOBELINE; MECAMYLAMINE; NALTREXONE; NICOTINE; NICOTINE GUM; PSYCHOTROPIC AGENT; SILVER;

ALCOHOL ABUSE; CANCER; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DEMOGRAPHY; DEPRESSION; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUNG DISEASE; MEDICAL RESEARCH; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SMOKELESS TOBACCO; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

EID: 10144221346     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.10.1     Document Type: Review

References (219)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed Washington, DC, APA 1994 [G]
2. Glassman AH: Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993; 150:546-553 [F]
3. US Department of Health and Human Services: Clinical Practice Guideline #18 Smoking Cessation. Washington, DC, US Government Printing Office, 1996 [E]
4. American Psychiatric Association Council on Research: Position statement on nicotine dependence. Am J Psychiatry 1995; 152:481-482 [G]
5. US Department of Health and Human Services: Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Washington, DC, US Government Printing Office, 1994 [F]
6. US Department of Health and Human Services: Bibliography on Smoking and Health: Selected Annotations. Washington, DC, US Government Printing Office, 1994 [G]
7. Silagy C, Gray S, Fowler G, Lancaster T: Development of a prospective register of smoking cessation trials. Control Clin Trials (in press) [E]
8. Hughes JR: Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatry 1993; 54:109-114 [F]
9. Hughes JR: Nicotine withdrawal, dependence, and abuse, in DSM-IV Sourcebook, vol 1. Edited by Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W. Washington, DC, American Psychiatric Association, 1994, pp 109-116 [F]
10. Hughes JR: Smoking as a drug dependence: a reply to Robinson and Pritchard. Psychopharmacology (Berl) 1993; 113:282-283 [G]
11. GIOVINO GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J: Epidemiology of tobacco use and dependence. Epidemiol Rev 1995, 17:48-65 [F]
12. Fagerstrom K, Schneider NG: Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12:159-182 [F]
13. Hughes JR, Gulliver SB, Fenwick JW, Cruser K, Valliere WA, Pepper SL, Shea PJ, Solomon LJ: Smoking cessation among self quitters. Health Psychol 1992; 11:331-334 [C]
14. Cohen S, Lichtenstein E, Prochaska JO, Rossi JS, Gritz FR, Carr CR, Orleans CT, Schoenbach VJ, Biener L, Abrams D, DiClemente CC, Curry S, Marlatt GA, Cumming KM, Emont SL, Giovino G, Ossip-Klein D: Debunking myths about self-quitting. Am Psychol 1989; 44:1355-1365 [A]
15. Hughes JR: Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother 1989; 43:11-17 [F]
16. Hughes JR, Higgins ST, Hatsukami D: Effects of abstinence from tobacco: a critical review, in Research Advances in Alcohol and Drug Problems, vol 10. Edited by Kozlowski LT, Annis HM, Cappell HD, Glaser FB, Goodstadt MS, Israel Y, Kalant H, Sellers EM, Vingilis ER. New York, Plenum, 1990, pp 317-398 [F]
17. Hughes JR, Hatsukami DK: The nicotine withdrawal syndrome: a brief review and update. Int J Smoking Cessation 1992, 1:21-26 [F]
18. US Department of Health and Human Services: Health Consequences of Smoking Cessation: A Report of the US Surgeon General. Washington, DC, US Government Printing Office, 1990 [F]
19. US Department of Health and Welfare: Smoking and Health: A Report of the Surgeon General. Washington, DC, US Government Printing Office, 1979 [F]
20. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr: Mortality from tobacco in developed countries: indirect estimation from national viral statistics. Lancet 1992; 339:1268-1278 [G]
21. Bartecchi CE, MacKenzie TD, Schrier RW: The human costs of tobacco use, part II. N Engl J Med 1994; 330:975-980 [F]
22. US Department of Health and Human Services: The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Washington, DC, US Government Printing Office, 1986 [F]
23. Office of Health and Environmental Assessment: Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. Washington, DC, US Government Printing Office, 1992 [F]
24. Hughes JR: Risk/benefit of nicotine replacement in smoking cessation. Drug Saf 1993; 8:49-56 [F]
25. Benowitz NL: Toxicity of nicotine: implications with regard to nicotine replacement therapy, in Nicotine Replacement: A Critical Evaluation. Edited by Pomerleau OF, Pomerleau CS, Fagerstrom KO, Henningfield JE, Hughes JR. New York, Alan R Liss, 1988, pp 187-217 [F]
26. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB: Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993; 54:670-679 [A]
27. US Department of Health and Human Services: National trends in smoking cessation, in The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Washington, DC, US Government Printing Office, 1990, pp 580-616 [F]
28. Hughes JR: Genetics of smoking: a brief review. Behavior Therapy 1986; 17:335-345 [F]
29. Heath AC, Madden PAF: Genetic influences on smoking behavior, in Behavior Genetic Approaches in Behavioral Medicine: Perspectives on Individual Differences. Edited by Turner JR, Cardon LR, Hewitt JK. New York, Plenum, 1995, pp 45-66 [F]
30. Swan GE, Carmelli D, Rosenman RH, Fabstig RR, Christian JC: Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences. J Subst Abuse 1990; 2:39-50 [B]
31. Breslau N, Kilbey MM, Andreski P: DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction 1994; 89:743-754 [G]
32. Hale KL, Hughes JR, Oliveto AH, Helzer JE, Higgins ST, Bickel WK, Cottler LB: Nicotine dependence in a population-based sample, in Problems of Drug Dependence, 1992: NIDA Research Monograph 132. Edited by Harris LS. Rockville, Md, National Institute on Drug Abuse, 1993, pp 181 [G]
33. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ: Nicotine dependence and schizophrenia. Hosp Comm Psychiatry 1994; 45:204-206 [F]
34. Hughes JR: Clinical implications of the association between smoking and alcoholism, in Alcohol and Tobacco: From Basic Science to Policy: NIAAA Research Monograph 30. Edited by Fertig J, Fuller R. Washington, DC, US Government Printing Office, 1995, pp 171-181 [F]
35. Klesges RC, Meyers AW, La Vasque ME: Smoking, body weight and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull 1989; 106:204-230 [F]
36. US Department of Health and Human Services: Tobacco use compared to other drug dependencies, in The Health Consequences of Smoking: Nicotine Addiction: A Report of the US Surgeon General. Washington, DC, US Government Printing Office, 1988, pp 241-376 [F]
37. Henningfield JE, Clayton R, Pollin W: Involvement of tobacco in alcoholism and illicit drug use. Br J Addict 1990; 85:279-292 [G]
38. American Psychiatric Association: Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry 1995; 152(Nov suppl):1-59 [G]
39. Prochaska JO, Goldstein MG: Process of smoking cessation: implications for clinicians. Clin Chest Med 1991; 12:727-735 [F]
40. Hughes JR: Applying harm reduction to smoking. Tobacco Control 1995; 4:S33-S38 [F]
41. Hughes JR: Long-term use of nicotine-replacement therapy, in New Developments in Nicotine-Delivery Systems. Edited by Henningfield JE, Stitzer ML. New York, Carlton, 1991, 64-71 [F]
42. Benowitz NL: Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319:1318-1330 [F]
43. Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce JP: Distribution of smokers by stage in three representative samples. Prev Med 1995; 24:401-411 [G]
44. Hall RG, Duhamel M, McClanahan R, Miles G, Nason C, Rosen S, Schiller P, Tao-Yonenaga L, Hall SM: Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J Nerv Ment Dis 1995; 183:468-471 [G]
45. Breslau N, Kilbey MM, Andreski P. Nicotine dependence and major depression: new evidence from a prospective investigation. Arch Gen Psychiatry 1993; 50:31-35 [C]
46. Breslau N: Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 1995; 25:95-101 [G]
47. Woody GE, Cottler LB, Cacciola J: Severity of dependence: data from the DSM-IV field trials. Addiction 1993; 88:1573-1579 [G]
48. Pomerleau CS, Majchrzak MJ, Pomerleau OF: Nicotine dependence and the Fagerstrom Tolerance Questionnaire: a brief review. J Subst Abuse 1989; 1:471-477 [F]
49. Orleans CT: Treating nicotine dependence in medical settings: a stepped-care model, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 145-161 [G]
50. Orleans CT, Glynn TJ, Manley MW, Slade JD: Minimal-contact quit smoking strategies for medical settings. Ibid, pp 181-220 [F]
51. US Department of Health and Human Services: Treatment of tobacco dependence, in The Health Consequences of Smoking: Nicotine Addiction. Washington, DC, US Government Printing Office, 1988, pp 459-560 [F]
52. Benowitz NL: The use of biologic fluid samples in assessing tobacco smoke consumption. NIDA Res Monogr 1983;48:6-26 [F]
53. Hughes JR: Treatment of nicotine dependence: is more better? JAMA 1995; 274:1390-1391 [F]
54. Lerman C, Orleans CT, Engstrom PF: Biological markers in smoking cessation treatment. Semin Oncology 1993; 20:359-367 [F]
55. Velicer WF, Prochaska JO, ROSSI JS, Snow MG: Assessing outcome in smoking cessation studies. Psychol Bull 1992; 111:23-41 [F]
56. Law M, Tang JL: An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155:1933-1941 [E]
57. Baillie A, Mattick RP, Hall W, Webster P: Meta-analytic review of the efficacy of smoking cessation interventions. Drug and Alcohol Rev 1994; 13:157-170 [E]
58. Kottke TE, Battista RN, DeFriese GH, Brekke ML: Attributes of successful smoking cessation interventions in medical practice: a meta-analysis of 39 controlled trials. JAMA 1988; 259: 2882-2889 [E]
59. Fiore MC: Cigarette smoking. Med Clin North Am 1992; 76: 289-547 [F]
60. Abrams DB: Treatment issues: towards a stepped-care model. Tobacco Control 1993; 2:S17-S37 [F]
61. Glynn TJ, Manley MW: How To Help Your Patients Stop Smoking. Washington, DC, US Government Printing Office, 1989 [G]
62. Sachs DPL: Advances in smoking cessation treatment. Current Pulmonology 1991; 12:139-198 [F]
63. Goldstern MG, Niaura R, Abrams DB: Pharmacological and behavioral treatment of nicotine dependence: nicotine as a drug of abuse, in Medical Psychiatric Practice, vol 1. Edited by Stoudemire A, Fogel BS. Washington, DC, American Psychiatric Press, 1991, pp 541-596 [F]
64. Sachs DPL, Leischow SJ: Pharmacological approaches to smoking cessation. Clin Chest Med 1991; 12:9-10 [F]
65. Hughes JR: Behavioral support programs for smoking cessation. Modern Medicine 1994; 61:22-26 [F]
66. Orleans CT, Slade JD (eds): Nicotine Addiction: Principles and Management. New York, Oxford University Press, 1993 [F]
67. Mattick RP, Baillie A, An Outline for Approaches to Smoking Cessation: Quality Assurance Project. Canberra, Australian Government Publishing Service, 1992 [F]
68. Hughes JR, Francis RJ: How to help psychiatric patients stop smoking. Psychiatr Serv 1995; 46:435-445 [G]
69. Hurt RD, Eberman KM, Slade JD, Karan L: Treating nicotine addiction in patients with other addictive disorders, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 310-326 [F]
70. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS: Standardized, individualized, interactive and personalized self-help programs for smoking cessation. Health Psychol 1993; 12:399-405 [A]
71. Schwartz JL: Methods of smoking cessation. Med Clin North Am 1992; 76:451-476 [E]
72. Schwartz JL: Review and Evaluation of Smoking Cessation Methods: The United States and Canada. Washington, DC, US Department of Health and Human Services, 1987 [E]
73. Gritz ER, Kristeller JL, Burns DM: Treating nicotine addiction in high-risk groups and patients with medical co-morbidity, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 279-309 [F]
74. Lando HA: Formal quit smoking treatments. Ibid, pp 221-244 [F]
75. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Kitchens K: The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol 1995; 63:388-399 [A]
76. French SA, Jeffery RW: Weight concerns and smoking: a literature review. Ann Behav Med 1995; 17:234-244 [F]
77. Gritz ER, Klesges RC, Meyers AW: The smoking and body weight relationship: implications for intervention and post-cessation weight control. Ann Behav Med 1989; 11:144-153 [F]
78. Hall SM, Tunstall CD, Vila KL, Duffy J: Weight gain prevention and smoking cessation: cautionary findings. Am J Public Health 1992; 82:799-803 [A]
79. Pine PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami DK, Allen S, Lando H: Smoking cessation in women concerned about weight. AmJ Public Health 1992; 82:1238-1243 [A]
80. McBride CM, French SA, Pirie PL, Jeffrey RW: Changes over time in weight concerns among women smokers engaged in the cessation process. Ann Behav Med (in press) [A]
81. Perkins KA: Issues in the prevention of weight gain after smoking cessation. Ann Behav Med 1994; 16:46-52 [F]
82. Shiffman SM: Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 1982; 50:71-86 [C]
83. Hughes JR, Olivero AH: Caffeine and alcohol intake as predictors of smoking cessation and tobacco withdrawal. J Subst Abuse 1993; 5:305-310 [C]
84. Oliveto AH, Hughes JR, Terry SY, Bickel WK, Higgins ST, Pepper SL, Fenwick JW: Effects of caffeine on tobacco withdrawal. Clin Pharmacol Ther 1991; 50:157-164 [A]
85. Hughes JR: Caffeine withdrawal, dependence, and abuse, in DSM-IV Sourcebook, vol 1. Edited by Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W. Washington, DC, American Psychiatric Association, 1994, pp 129-134 [F]
86. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB: Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994; 271:589-594 [C]
87. Curry SJ: Self-help interventions for smoking cessation. J Consult Clin Psychol 1993; 61:790-803 [F]
88. Brown RA, Goldstein MG, Niaura R, Emmons, KM, Abrams DB: Nicotine dependence: assessment and management, in Psychiatric Care of the Medical Patient. Edited by Stoudemire A, Fogel BS. New York, Oxford University Press, 1993, pp 877-901 [F]
89. Fisher EB Jr, Lichtenstein E, Haire-Joshu D, Morgan GD, Rehberg HR: Methods, successes, and failures of smoking cessation programs. Annu Rev Med 1993; 44:481-513 [F]
90. Glasgow RE, Lichtcnstein E: Long-term effects of behavioral smoking cessation interventions. Behavior Therapy 1987; 18: 297-324 [F]
91. Mermelstein RJ, Karnatz T, Retchmann S: Smoking, in Principles and Practice of Relapse Prevention. Edited by Wilson PH. New York, Guilford Press, 1992, pp 43-68 [F]
92. Viswesvaran C, Schmidt FL: A meta-analytic tic comparison of the effectiveness of smoking cessation methods. J Appl Psychol 1992; 77:554-561 [E]
93. Curry S, McBride C: Relapse prevention for smoking cessation: review and evaluation of concepts and interventions. Annu Rev Public Health 1994; 15:345-366 [F]
94. Gruder CL, Mermelstein RJ, Kirkendol S, Hedeker D, Wong SC, Schreckengost J, Warnecke RB, Burzette R, Miller TQ: Effects of social support and relapse prevention training as adjuncts to a televised smoking-cessation intervention. J Consult Clin Psychol 1993; 61:113-120 [A]
95. Havassy B, Hall S, Wasserman D: Social support and relapse: commonalities among alcoholics, opiate users and cigarette smokers. Addict Behav 1991; 16:235-246 [C]
96. Corty E, McFall R: Response prevention in the treatment of cigarette smoking. Addict Behav 1984; 9:405-408 [A]
97. Lowe M, Green L, Kurtz S, Ashenberg Z, Fisher EJ: Self-initiated, cue extinction, and covert sensitization procedures in smoking cessation. J Behav Med 1980; 3:357-372 [A]
98. Raw M, Jarvis M, Feyerabend C, Russell MAH: Comparison of nicotine chewing gum and psychological treatments for dependent smokers. Br Med J 1980; 281:481-482 [B]
99. Raw M, Russell MAH: Rapid smoking, cue exposure and support in the modification of smoking. Behav Res Ther 1980; 18: 363-372 [A]
100. Davis RM: The delivery of smoking cessation services: current status and future needs. Tobacco Control 1993; 2:S63-S78 [F]
101. Hughes JR: Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies and suggestions for further research. J Consult Clin Psychol 1993; 61:751-760 [E]
102. Digiusto E, Bird KD: Matching smokers to treatment: self-control versus social support. J Consult Clin Psychol 1995; 63:290-295 [A]
103. Zelman DC, Brandon TH, Jorenby DE, Baker TB: Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol 1992; 60: 943-952 [A]
104. Gould RA, Clum GA: A meta-analysis of self-help treatment approaches. Clin Psychol Rev 1993; 13:169-186 [E]
105. Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ: Telephone counseling for smoking cessation: rationale and review of evidence. Health Education Res 1996; 11:243-257 [F]
106. Orleans CT, Schoenbach VJ, Wagner EH, Quade D, Salmon MA, Pearson DC, Fiedler J, Porter CQ, Kaplan BH: Self-help quit smoking interventions: effects of self-help materials, social support instructions and telephone counseling. J Consult Clin Psychol 1991; 59:439-448 [A]
107. COMMIT Research Group: Community intervention trial for smoking cessation (COMMIT), II: changes in adult cigarette smoking prevalence. Am J Public Health 1995; 85:193-200 [A]
108. Strecher VJ, Kreuter M, Den Boer DJ, Kobrin S, Hospers HJ, Skinner CS: The effects of computer-tailored smoking cessation messages in family practice settings. J Fam Pract 1994; 39:262-270 [A]
109. Hajek P, Belcher M, Stapleton J: Enhancing the impact of groups: an evaluation of two group formats for smokers. Br J Clin Psychol 1985; 24:289-294 [A]
110. Casey K: If Only 1 Could Quit: Recovering From Nicotine Addiction. Center City, Minn, Hazelden Foundation, 1987 [G]
111. Marcus BH, Albrecht AE, Niaura RS, Abrams DB, Thompson PD: Usefulness of physical exercise for maintaining smoking cessation in women. Am J Cardiol 1991; 68:406-407 [A]
112. Marcus BH, Albrecht AE, Niaura RS, Taylor ER, Simkin LR, Feder SI, Abrams DB, Thompson PD: Exercise enhances the maintenance of smoking cessation in women. Addict Behav 1995; 20:87-92 [A]
113. Hughes JR: Treatment of nicotine dependence, in Pharmacological Aspects of Drug Dependence: Toward an Integrative Neurobehavioral Approach: Handbook of Experimental Psychology Series, vol. 11. Edited by Schuster CR, Gust SW, Kuhar MJ. New York, Springer-Verlag, 1996, pp 599-618 [F]
114. Jarvik ME, Henningfield JE: Pharmacological adjuncts for the treatment of tobacco dependence, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 245-261 [F]
115. Silagy C, Mant D, Fowler G, Lodge M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343:139-142 [E]
116. Lee EW, D'Alonzo GE: Cigarette smoking, nicotine addiction and its pharmacologic treatment. Arch Intern Med 1993; 153: 34-48 [F]
117. Nunn-Thompson CL, Simon PA: Pharmacotherapy for smoking cessation. Clin Pharm 1989; 8:710-720 [F]
118. Pomerleau O, Pomerleau C, Fagerstrom K, Henningfield JE, Hughes JR: Nicotine Replacement: A Critical Evaluation. New York, Haworth Press, 1988 [F]
119. Fagerstrom K: Combined use of nicotine replacement products. Health Values 1994; 18:15-20 [F]
120. Rose JE: Transdermal nicotine and nasal nicotine administration as smoking cessation treatments, in The Clinical Management of Nicotine Dependence. Edited by Cocores JA. New York, Springer-Verlag, 1991, pp 196-207 [F]
121. Prignot J: Pharmacological approach to smoking cessation. Eur Respir J 1989; 2:550-560 [F]
122. Jackson PH, Stapleton JA, Russell MAH, Merriman RJ: Predictors of outcome in a general practitioner intervention against smoking. Prev Med 1986; 15:244-253 [A]
123. Hughes JR: Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 1994; 6:197-203 [F]
124. Cepeda-Benito A: Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 1993; 61:822-830 [E]
125. Covey LS, Glassman AH: A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. Br J Addict 1991; 86:991-998 [E]
126. Gourlay SG, McNeil JJ: Antismokmg products. Med J Aust 1990; 153:699-707 [C]
127. Tang JL, Law M, Wald N: How effective is nicotine replacement therapy in helping people to stop smoking? Br Med J 1994; 308:21-25 [E]
128. Hughes JR: Combining behavioral therapy and pharmacotherapy for smoking cessation: an update, in Integrating Behavior Therapies With Medication in the Treatment of Drug Dependence: NIDA Research Monograph 150. Edited by Onken LS, Blaine JD, Boren JJ, Rockville, Md, National Institute on Drug Abuse, 1995, pp 92-109 [E]
129. Hughes JR: Combined psychological and nicotine gum treatment for smoking: a critical review. J Subst Abuse 1991; 3:337-350 [E]
130. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED: Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993; 33: 23-29 [G]
131. Palmer KJ, Faulds D: Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as an aid to smoking cessation. Drugs 1992; 44:498-529 [F]
132. Hughes JR, Glaser M: Transdermal nicotine for smoking cessation. Health Values 1993; 17:24-31 [F]
133. Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271:1940-1946 [E]
134. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE: Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 1992; 52:627-634 [A]
135. Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, Steinberg C: Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995; 90:1671-1682 [A]
136. Sutherland G, Russell MAH, Stapleton J, Feyerabend C, Ferno O: Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology (Berl) 1992; 108:512-518 [G]
137. Leischow SJ: Nicotine vaporiser: review of results, in Future Directions in Nicotine Replacement Therapy. Chester, England, Adis, 1994, pp 99-103 [F]
138. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F: A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993; 269:1268-1271 [A]
139. Rose JE, Behm FM: Refined cigarette smoke as a method for reducing nicotine intake. Pharmacol Biochem Behav 1987; 28: 305-310 [A]
140. Russell MAH, Jarvis MJ, Sutherland G, Feyerabend C: Nicotine replacement in smoking cessation. JAMA 1987; 257:3262-3265 [G]
141. Sutherland G, Russell MAH, Stapleton JA, Feyerabend C: Glycerol particle cigarettes: a less harmful option for chronic smokers. Thorax 1993; 48:385-387 [A]
142. Davison GC, Rosen RC: Lobeline and reduction of cigarette smoking. Psychol Rep 1972; 31:443-456 [A]
143. Sachs DPL: Effectiveness of 4 mg nicotine polacrilex for the initial treatment of high-dependent smokers. Arch Intern Med 1995; 155:1973-1980 [A]
144. Rose JE, Behm FM: Lobeline aerosol reduces craving for cigarettes, in Proceedings of the 1st Meeting of the Society for Research on Nicotine and Tobacco. Bethesda, Md, Society for Research on Nicotine and Tobacco, 1995, p 65 [A]
145. Lam WL, Sze PC, Sacks HS, Chalmer TC: Meta-analysis of randomized controlled trials of nicotine chewing gum. Lancet 1987; 2:27-29 [E]
146. Po ALW: Transdermal nicotine in smoking cessation. Eur J Clin Pharmacol 1993; 45:519-528 [E]
147. Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, Belcher M, Feyerabend C: Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340:324-329 [A]
148. Hjalmarson A, Franzon M, Westin A, Wiklund O: Effect of nicotine nasal spray on smoking cessation. Arch Intern Med 1994; 154:2567-2572 [A]
149. US Department of Health and Human Services: Smoking deterrent drug products for over-the-counter human use: establishment of a monograph. Federal Register 1982; 47:490-500 [G]
150. Hurt RD, Offord KP, Lauger GG, Marusic Z, Fagerstrom K, Enright PL, Scanlon PD: Cessation of long-term nicotine gum use: a prospective, randomized trial. Addiction 1995; 90:407-413 [A]
151. Fiore MC, Jorenby DE, Baker TB, Kenford SL: Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA 1992; 268:2687-2694 [F]
152. Wetter DW, Fiore MC, Baker TR, Young TB: Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol 1995; 63:658-667 [A]
153. Cox JL: Algorithms for nicotine withdrawal therapy. Health Values 1993; 17:41-50 [G]
154. Hughes JR: An algorithm for smoking cessation. Arch Fam Med 1994; 3:280-285 [G]
155. Fagerstrom KO, Melin B: Nicotine chewing gum in smoking cessation: efficacy, nicotine dependence, therapy duration, and clinical recommendations, NIDA Res Monogr 1985; 53:102-109 [F]
156. Hatsukami DK, Huber M, Callies A, Skoog K: Physical dependence on nicotine gum: effect of duration of use. Psychopharmacology (Berl) 1993; 111:449-456 [A]
157. Clarke PBS: Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 1991; 86:501-505 [F]
158. Stolerman IP, Goldfarb T, Fink R, Jarvik ME: Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 1973; 28:247-259 [F]
159. Rose JE, Levin ED: Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacol Biochem Behav 1991; 41:219-226 [A]
160. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV: Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 1994; 56:86-99 [G]
161. Rounsaville BJ: Can psychotherapy rescue naltrexone treatment of opioid addiction?, in Integrating Behavior Therapies With Medication in the Treatment of Drug Dependence: NIDA Research Monograph 150. Edited by Onken LS, Blame JD, Boren JJ. Rockville, Md, National Institute on Drug Abuse, 1995, pp 37-52 [F]
162. Pomerleau OF, Pomerleau CS: Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 1984; 8:503-513 [F]
163. Sutherland G, Stapleton JA, Russell MAH, Feyerabend C: Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology (Berl) 1995; 120:418-425 [A]
164. Fuller RK: Antidipsotropic medications, in Handbook of Alcoholism Treatment Approaches: Effective Alternatives. Edited by Hester RK, Miller WR. New York, Pergamon Press, 1989, pp 117-127 [F]
165. Gourlay SG, Benowitz NL: Is clonidine an effective smoking cessation therapy? Drugs 1995; 50:197-207 [E]
166. Parrott AC: Stress modulation over the day in cigarette smokers. Addiction 1995; 90:233-244 [G]
167. Hall SM, Munoz RF, Reus VI, Sees KL: Nicotine, negative affect, and depression. J Consult Clin Psychol 1993; 61:761-767 [F]
168. Humfleet G, Hall S, Reus V, Sees K, Mufloz R, Triffleman E: The efficacy of nortriptyline as an adjunct to psychological treatment for smokers with and without depressive histories, in Problems of Drug Dependence, 1995: NIDA Research Monograph, vol. 162. Edited by Adler M. Rockville, Md, National Institute on Drug Abuse, 1996, p 334 [A]
169. Robinson MD, Anastasio GD, Little JM, Sigmon JL, Menscer D, Pettice YJ, Norton HJ: Ritalin for nicotine withdrawal: Nesbitt's paradox revisited. Addict Behav 1995; 20:481-490 [B]
170. Rose JE, Behm FM: Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. Drug Alcohol Depend 1994; 34:225-229 [A]
171. Behm FM, Rose JE: Reducing craving for cigarettes while decreasing smoking intake using capsaicin-enhanced low tar cigarettes. Exp Clin Psychopharmacol 1994; 2:143-153 [A]
172. Butschky MF, Bailey D, Henningfield JE, Pickworth WB: Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 1995; 50:91-96 [A]
173. Levin ED, Behm FM, Rose JE: The use of flavor in cigarette substitutes. Drug Alcohol Depend 1990; 26:155-160 [A]
174. Behm FM, Levin ED, Lee YK, Rose JE: Low-nicotine regenerated smoke aerosol reduces desire for cigarettes. J Subst Abuse 1990; 2:237-247 [A]
175. Westman EC, Behm FM, Rose JE: Airway sensory replacement combined with nicotine replacement for smoking cessation. Chest 1995; 107:1358-1364 [A]
176. Behm FM, Schur C, Levin ED, Tashkin DP, Rose JE: Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend 1993; 31:131-138 [A]
177. Schwartz JL: Evaluation of acupuncture as a treatment for smoking. Am J Acupuncture 1988; 16:135-142 [E]
178. Ter-Riet G, Kleinjnen J, Knipschild P: A meta-analysis of studies into the effect of acupuncture on addiction. Br J Gen Pract 1990; 40:379-382 [E]
179. Glasgow RE, Klesges RC, Klesges LM, Vasey MW, Gunnarson DF: Long-term effects of a controlled smoking program: a 2/2 year follow-up. Behavior Therapy 1985; 16:303-307 [F]
180. Hall SM, Munoz RF, Reus VI: Cognitive-behavioral intervention increases abstinence rates for depressive history smokers. J Consult Clin Psychol 1994; 62:141-146 [A]
181. Dalack GW, Glassman AH: A clinical approach to help psychiatric patients with smoking cessation. Psychiatr Q 1992; 63:27-38 [G]
182. Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, Surawicz TS, Davis RM: Methods used to quit smoking in the United States. JAMA 1990; 263:2760-2765 [G]
183. Hughes JR: Problems of nicotine gum, in Pharmacologic Treatment of Tobacco Dependence: Proceedings of the World Congress, November 3-5, 1985. Edited by Ockene JK. Cambridge, Mass, Institute for the Study of Smoking Behavior and Policy, 1986, pp 141-147 [F]
184. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen A, Forchammer H, Stockner M: Effect of nicotine chewing gum in combination with group counseling in the cessation of smoking. N Engl J Med 1988; 318:15-27 [A]
185. Killen JD, Fortmann SP, Newman B, Varady A: Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990; 58:85-92 [A]
186. Hughes JR: Smoking and alcoholism, in Behavioral Approaches to Addiction. Edited by Hatsukami DK, Cox J. New York, Cahners, 1994, pp 1-3 [G]
187. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ: Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. Br Med J 1995; 311:363-366 [A]
188. Tonnesen P, Norregaard J, Sawe U, Simonsen K: Recycling with nicotine patches in smoking cessation. Addiction 1993; 88:533-539 [A]
189. Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM: Inpatient treatment of severe nicotine dependence. Mayo Clin Proc 1992; 67:823-828 [B]
190. Resnick MP: Treating nicotine addiction in patients with psychiatric co-morbidity, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 327-336 [F]
191. Hughes JR, Higgins ST, Bickel WK: Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addictions 1994; 89:1461-1470 [F]
192. Haring C, Barnas C, Sana A, Humpel C, Fleischhacker WW: Dose-related plasma levels of clozapine. J Clin Psychopharmacol 1989; 9:71-72 [G]
193. Working Group for the Study of Transdermal Nicotine in Patients With Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154:989-995 [A]
194. Hurt RD, Eberman KM, Croghan IT, Offord KP, Davis LJ Jr, Morse RM, Palmen MA, Bruce BK: Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial. Alcohol Clin Exp Res 1994; 18:867-872 [B]
195. Hall SM, Munoz RF, Reus VI, Sees KL: Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo controlled study. J Consult Clin Psychol (in press) [A]
196. Lohr JB, Flynn K: Smoking and schizophrenia. Schizophr Res 1992; 8:93-102 [F]
197. US Department of Health and Human Services: Psychological and behavioral consequences and correlates of smoking cessation, in Health Benefits of Smoking Cessation: A Report of the US Surgeon General. Washington, DC, US Government Printing Office, 1990, pp 517-578 [F]
198. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, Owens GR, Scanlon PD, Tashkin DP, Wise RA: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272:1497-1505 [A]
199. Kennedy JA, Crowley TJ, Cottler LB, Mager DE: Substance use diagnoses in smokers with lung disease. Am J Addiction 1993; 2:126-130 [G]
200. Rimer BK, Orleans CT: Older smokers, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 385-395 [F]
201. Rimer BK, Orleans CT, Fleisher L, Cristinzio S, Resch N, Telepchak J, Keintz MK: Does tailoring matter? the impact of a tailored guide on ratings and short-term smoking-related outcomes for older smokers. Health Education Res 1994; 9:69-84 [A]
202. Repsher LH, Transdermal Nicotine Study Group: Smoking cessation by women and older persons: results from the Transdermal Nicotine Study Group. Modern Medicine 1994; 62:34-38 [A]
203. Solomon LJ, Flynn BS: Women who smoke, in Nicotine Addiction: Principles
204. Grunberg NE, Winders SE, Wewers ME: Gender differences in tobacco use. Health Psychol 1991; 10:143-153 [F]
205. US Department of Health and Human Services: The Health Consequences of Smoking For Women: A Report of the Surgeon General. Washington, DC, US Government Printing Office, 1980 [F]
206. Benowitz NL: Nicotine replacement therapy during pregnancy. JAMA 1991; 266:3174-3177 [F]
207. Naeye RL: Cognitive and behavioral abnormalities in children whose mothers smoked cigarettes during pregnancy. J Dev Behav Pediatr 1992; 13:425-428 [G]
208. Ramirez AG, Gallion KJ: Nicotine dependence among blacks and Hispanics, in Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade JD. New York, Oxford University Press, 1993, pp 350-364 [F]
209. Marsh A, McKay S: Poor Smokers. London, Policy Studies Institute, 1994 [F]
210. Howard TS, Hughes JR: Smoking cessation and the nicotine patch (letter). JAMA 1995; 274:214 [B]
211. US Department of Health and Human Services: The Health Consequences of Using Smokeless Tobacco: A Report of the Advisory Committee to the Surgeon General. Washington, DC, US Government Printing Office, 1986 [F]
212. US Department of Health and Human Services: Smokeless Tobacco or Health: Smoking and Tobacco Control Monograph 2. Washington, DC, US Government Printing Office, 1992 [F]
213. US Department of Health and Human Services: The Health Consequences of Smoking: Nicotine Addiction: A Report of the US Surgeon General. Washington, DC, US Government Printing Office, 1988 [F]
214. Hatsukami D, Jensen J, Allen S, Grillo M, Bliss R: The effects of behavioral and pharmacological treatment on smokeless tobacco users. J Consult Clin Psychol 1996; 64:153-161 [A]
215. Ockene JK, Kristeller JL: Tobacco, in The American Psychiatric Press Textbook of Substance Abuse Tteatment. Edited by Galanter M, Kleber HD. Washington, DC, American Psychiatric Press, 1994, pp 157-177 [F]
216. Benowitz NL: Nicotine replacement therapy: what has been accomplished. Can we do better? Drugs 1993; 45:157-170 [F]
217. Jarvik ME, Schneider NG: Nicotine, in Substance Abuse: A Comprehensive Textbook. Edited by Lowinson JH, Ruiz P, Millman RB, Langrod JG. Baltimore, Williams & Wilkins, 1992, pp 334-356 [F]
218. Anthony JC, Warner LA, Kessler RC: Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2:244-268 [G]
219. Fagerstrom K, Kunze M, Schoberberger JC, Breslau N, Hughes JR, Hurt RD, Puska P, Ramstrom L, Zatonski W: Nicotine dependence versus prevalence of smoking: comparisons between countries and categories of smokers. Tobacco Control 1996; 5:52-56 [G]